Logo of plosonePLoS OneView this ArticleSubmit to PLoSGet E-mail AlertsContact UsPublic Library of Science (PLoS)
PLoS One. 2011; 6(7): e22622.
Published online 2011 Jul 27. doi:  10.1371/journal.pone.0022622
PMCID: PMC3144925

Sh3pxd2b Mice Are a Model for Craniofacial Dysmorphology and Otitis Media

Bruce Riley, Editor


Craniofacial defects that occur through gene mutation during development increase vulnerability to eustachian tube dysfunction. These defects can lead to an increased incidence of otitis media. We examined the effects of a mutation in the Sh3pxd2b gene (Sh3pxd2bnee) on the progression of otitis media and hearing impairment at various developmental stages. We found that all mice that had the Sh3pxd2bnee mutation went on to develop craniofacial dysmorphologies and subsequently otitis media, by as early as 11 days of age. We found noteworthy changes in cilia and goblet cells of the middle ear mucosa in Sh3pxd2bnee mutant mice using scanning electronic microscopy. By measuring craniofacial dimensions, we determined for the first time in an animal model that this mouse has altered eustachian tube morphology consistent with a more horizontal position of the eustachian tube. All mutants were found to have hearing impairment. Expression of TNF-α and TLR2, which correlates with inflammation in otitis media, was up-regulated in the ears of mutant mice when examined by immunohistochemistry and semi-quantitative RT-PCR. The mouse model with a mutation in the Sh3pxd2b gene (Sh3pxd2bnee) mirrors craniofacial dysmorphology and otitis media in humans.


Otitis media (OM) is a prevalent problem in children under the age of 15 [1], [2]. OM can be acute or chronic and can be accompanied by excessive middle ear effusion, an accumulation of fluid in the middle ear [1], [2], [3]. By the age of 10, about 80% of children have had at least one case of OM with effusion [3], [4], [5], [6], caused by eustachian tube dysfunction. This is the leading cause of impaired hearing in children [7]. The eustachian tube is the only ventilation pathway of the middle ear cavity, interconnecting the nasopharynx and the external environment. Thus, it is crucial in clearing the middle ear of excessive effusion and in balancing middle ear pressure [8], [9], [10]. Malfunction or malformation of the bones and/or muscles around the eustachian tube can cause obstruction or a patulous condition, which may result in excessive middle ear fluid accumulation or retrograde infection through the eustachian tube [11], [12], [13]. All evidence indicates a crucial role for the eustachian tube in OM pathogenesis.

Craniofacial development influences eustachian tube function. Craniofacial dysmorphology may change the position or angle of the eustachian tube, and/or the location of surrounding muscles that control the eustachian tube. These changes can cause eustachian tube obstruction or incorrect opening and, ultimately, OM [14], [15], [16], [17], [18], [19]. Cleft palate malformation has been clearly associated with OM [20], [21]. Patients affected by craniofacial dysmorphology, but not by a cleft palate, show increased incidence of OM [15], [22]. Thus, although these conditions frequently occur together, one is sufficient for predisposition to OM.

The expression of mouse protein SH3PXD2B (SH3 and PX domains 2B, MGI: 2442062; synonymous with human TKS4) has recently been correlated with formation of podosomes and invadopodia, which mediate interactions between cells (normal and cancerous, respectively) and the extracellular matrix [23]. The SH3PXD2B protein is a member of the src tyrosine kinase substrate family. SH3PXD2B can recruit the membrane type-1 matrix metalloproteinase (MT1-MMP), resulting in extracellular matrix degeneration [23], [24]. Extracellular matrix remodeling is a significant part of normal postnatal development of several tissues and also in cancer cell invasion and migration [25], [26], [27]. The Sh3pxd2bnee mutation spontaneously arose in the mouse strain B10.A-H2h4/(4R)SgDVEg that was bred in the Jackson Laboratory (Bar Harbor, ME, USA). This mutant bears a single base-pair deletion in the last exon of the Sh3pxd2b gene on chromosome 11, resulting in a frameshift mutation and premature stop codon, thus eliminating the third and fourth SH3 domains of the SH3PXD2B protein [23], [24], [28]. Sh3pxd2bnee causes a craniofacial dysmorphology phenotype featuring a domed skull, shortened maxilla, shortened nose, glaucoma, growth retardation, adipose defects, and hearing impairment, all reported previously [24], [28]. These craniofacial defects can lead to OM, among other defects. Humans with Frank-ter Haar syndrome have a Sh3pxd2b gene defect that results in craniofacial dysmorphology, skeletal dysplasia, and eye and cardiac abnormalities, closely resembling the mouse phenotype [28].

Here, we show that the Sh3pxd2bnee mutation leads to progressive OM in mice through defects in craniofacial structure. Sh3pxd2bnee mutant mice exhibited a specific craniofacial dysmorphology and eustachian tube alteration and all mutants developed OM with onset as early as 11 days after birth. Mutant mice showed progressive hearing impairment, tympanic membrane retraction, and upregulated TNF-α and TLR2 in the middle ear. This evidence demonstrates the similarities in development and progression of OM between mice and humans affected by craniofacial dysmorphology.

Materials and Methods

Mouse husbandry and genotype

Sh3pxd2dnee heterozygous mice were obtained from the Jackson Laboratory (Bar Harbor, ME) and bred at the Wolstein Animal Research Facility at Case Western Reserve University. Because of previously reported infertility in homozygous mutants [24], the strain was maintained by heterozygous cross-mating. 52 homozygous Sh3pxd2bnee mutant mice and 66 wild-type littermate mice, from 6 days to 3 months of age, were used. All mice were genotyped by PCR and RsaI restriction enzyme (New England Biolabs) digestion methods as reported previously [24]. Experimental procedures were reviewed and approved by the Health Sciences IACUC of Case Western Reserve University. (Protocol numbers: 2008-0174 and 2008-0156).

Gross craniofacial phenotype and macroscopic ear observations

Lateral view photos of 2.5-month-old Sh3pxd2bnee mutant mice (n = 4) and wild-type littermate control mice (n = 4) were taken by digital camera (Canon 450D, Japan). Observation and comparison of the features of this mutant were made directly from the photos. Male Sh3pxd2bnee mutant mice and male wild-type littermate control mice were sacrificed by CO2 asphyxiation at a given time point after birth (day 6, day 11, day 14, day 16, day 21, n = 4 each phenotype at each time point); then mice were skinned and observed under a macroscope (Leica S6D, Germany). Ear and tympanic membrane photos were taken for comparison.

Histological preparation of middle and inner ears

Bullae (including both middle and inner ear) were isolated from ears of control (n = 4 mice) and Sh3pxd2bnee (n = 3) mice at various time points (ages 6, 11, 16 and 21 days, and 2.5 months; 4 mice per age-group) for gross and histological pathology examination. After dissection, bullae were fixed in 4% PFA for 24 hours and then decalcified in 10% EDTA. For 11- to 21-day-old mice, samples were decalcified for 7 days before embedding in paraffin for sectioning. For 6- to 15-month-old mice, decalcification was for 21 days. Then samples were serially sectioned at 7 µm thickness and mounted onto slides.

Hematoxylin and eosin staining; Mayer's mucicarmine staining

For hematoxylin and eosin (H&E) staining, a standard protocol from Rosen's lab was used (http://www.bcm.edu/rosenlab). Mayer's mucicarmine staining was used to identify goblet cells in the middle ear mucosa following the manufacturer's protocol (Electron Microscopy Sciences). Sections were examined under a light microscope (Leica DFC500, Germany). Images were acquired at 5 to 63× final magnification.

Scanning electronic microscopy

Bullae were isolated from skulls of 21-day-old control and Sh3pxd2bnee mice (n = 4 mice, each genotype). Samples were placed in 2.5% gluteraldehyde in cacodylic acid in 0.1 M phosphate buffer (pH = 7.2) for 36 hours. After decalcification in 10% EDTA for 7 days, middle ear cavities were dissected from the bullae and then dehydrated in serial solutions of ethanol (60%, 70%, 80%, 95%, 100%) for 15 minutes each, with a second soak in 100% ethanol. Each middle ear cavity was subjected to carbon dioxide critical point drying, sputter-coated with 60/40 gold-palladium, and then viewed under a high-resolution scanning electron microscope (Hitachi S-4500, Japan).

Scoring system for pathology of middle and inner ears

A scoring system of −/+/++/+++ was used to assess the severity of pathology in middle and inner ears. Symbols were assigned as follows: −, absence of pathology; +, very scarce pathology in the middle or inner ear; ++, pathology prevalent, but not spanning the entire middle or inner ear; +++, pathology spanning the entire middle or inner ear. The scored pathologies included middle ear effusion, inflammatory cell infiltration, tissue proliferation, goblet cell density, and inner ear effusion. A chi-square test was used to evaluate the semi-quantitative data. This method has been reported in otitis media studies [29], [30].

Skull preparation and craniofacial measurement

To measure craniofacial dimensions, skulls were dissected and removed from mutant (n = 8) and control (n = 9) mice at age 3 months. The skulls were macerated in 1% KOH overnight to remove soft tissue and then stained with alizarin red, as previously described by M.C. Green [31]. To measure skull dimensions, a hand-held digital caliper (General Tools & Instruments) of 0.01 mm resolution was used. This method was previously validated for accuracy and precision [24], [32]. 44 landmarks were adapted from Dr. Joan Richtsmeier's publication [32], and from the standard measurement protocol in the craniofacial mutant source (Jackson Laboratory, http://craniofacial.jax.org/standard_protocols.html). The angle between the midline of the skull base and the bony part of the eustachian tube was measured for mutants and controls. Skulls were examined under an anatomical microscope and the skull base was photographed. Screen ruler software MB-Ruler 4.0 (Markus Bader, http://www.markus-bader.de/MB-Ruler/download.htm) was used to precisely locate the lines for angle measurement and to perform measurements. Measurement data were analyzed using the Student t test.

Time-course ABR thresholds

Auditory-evoked brain stem response (ABR) was used to evaluate hearing in Sh3pxd2bnee mutant mice. The method has been reported previously [33]. Mice were anesthetized with avertin (0.5 mg/g body mass). A computer-aided evoked potential system (Intelligent Hearing Systems) was used to record ABR thresholds for Sh3pxd2bnee mutant and control mice from 1 to 6 months of age. Student t test was used to analyze the mean ABR thresholds at each time point.

Semi-quantitative RT-PCR

RNA was isolated from the bullae of four mutant and four control 21-day-old mice using a pure-Link TM Micro-to-Midi Total RNA Purification System (Invitrogen). The SuperScript III First-Strand Synthesis System for RT-PCR was used to synthesize cDNA. Relative mRNA expression levels for Tnf-α and Tlr2 were determined by by PCR using Gapdh as the positive control. The primers for these genes were previously described [30], [34].

Primers for Gapdh, forward: AACTTTGGCATTGTGGAAGG, reverse: GGAGACAACCTGGTCCTCAG, yield a 351 bp product. For Tnf-α, forward: CCACCACGCTCTTCTGTCTAC, reverse: CCTTGAAGAGAACCTGGGAGT, yield a 303 bp product. For Tlr2, forward: GAGCGAGCTGGGTAAAGTAGAAA, reverse: AGCCGAGGCAAGAACAAAGA, yield a 528 bp product. PCR was performed using Taq DNA polymerase (New England Biolabs) with the following amplification conditions: denaturation at 94°C for 2 min; followed by 31 cycles of 94°C for 30 sec, 56°C for 40 sec, 72°C for 50 sec; then extension at 72°C for 5 min. PCR products were subjected to 1.5% agarose gel electrophoresis. To evaluate relative gene transcription levels, a semi-quantitative method was used: Image J software (NIH) was used to collect the gray intensity values of the Tnf-α and Tlr2 PCR bands, which were corrected by the coefficient of Gapdh gene expression of the same sample. Student t test was used to analyze differences between relative gray intensity of PCR bands. The method has been reported previously [30].

Immunostaining for TNF-α and TLR2

Middle ear paraffin sections were deparaffinized by immersion in xylene twice, 5 min each; rehydrated in sequential aliquots of 100%, 95%, 80%, and 70% ethanol, 5 min each; and finally, washed in water, 3 min. Then sections were covered with a trypsin working solution (containing 0.1% calcium chloride [pH 7.8]) and incubated 20 min at 37°C in a humidified incubator. Sections were cooled and washed twice with PBS, 5 min each. Then 0.2% Triton X-100 was added to sections for 5 min, followed by 2 more washes in PBS, 5 min each. Next, blocking solution (3% goat serum and 2% BSA) was applied for 1 hour followed by primary antibodies anti-TNF-α (1∶200 dilution) (Abcam, catalog #ab9739) and anti-TLR2 (1∶400 dilution)(Abcam, catalog #ab24192) incubated overnight at 4°C. The next day, sections were washed twice, 5 min each, in PBS; secondary antibody conjugated to Alexa Fluor 488 (1∶500 dilution; Invitrogen) was applied at room temperature for 1 hr. Sections were washed twice with PBS; propidium iodide (10 µg/ml, Invitrogen, catalog #P1304MP) was applied at room temperature for 15 min to counterstain the nuclei. Then sections were mounted in VECTASHIELD® Mounting Medium (Vector Laboratories, Inc.) and observed under an immunofluorescence microscope (Leica DFC500). Images were acquired at 5 to 63× final magnification.


Gross examination of craniofacial structures and ears

At 2.5 months of age, homozygous mutant mice exhibited obvious craniofacial dysmorphology (n = 4, each phenotype, Figure 1A) compared to wild-type controls. By anatomical microscopy (Leica S6D), OM was detected in mice as young as 11 days old (Figure 1B). The mutant mice showed severe middle ear effusion, sometimes accompanied by tympanic membrane retraction (Figure 1D) resembling human OM pathology [35], [36]. OM was detected in all mutant mice over 11 days of age, in contrast to the wild-type control mice.

Figure 1
Gross phenotype in Sh3pxd2bnee mutant mice.

Histological observation of middle ears

Middle ear pathology was assessed at various stages to track OM progression. In 6-day-old mice, middle ear cavitation had already begun both in the Sh3pxd2bnee mutant mice and wild-type littermate control mice. Cavitation of the middle ear was larger and appeared to proceed earlier in control mice than in mutants (Figure 2A–D), but by 11 days, relatively normal development was accompanied by effusion in the middle ear cavities of mutant mice only. Furthermore, these middle ears also showed inflammatory cell infiltration and thickened epithelia (Figure 2E–H). In 16-day-old mice, epithelial thickening continued and inflammatory cell numbers increased in the middle ears of mutant mice (Figure 2I–L); the trend continued in 21-day-old mutant mice. At 21 days, inflammatory cells had spread throughout the middle ear cavities of mutant mice as OM progressed and became more severe with age. Control mice at 21 days still showed no OM pathology (Figure 2O,P). At 2.5 months in mutant mice, the previous middle ear pathology was accompanied by fibroblastic proliferation and capillary hyperplasia (Figure 3A,B), a higher density of goblet cells in the middle ear mucosa revealed by Mayer's mucicarmine staining (Figure 3C,D), and a thickened tympanic membrane (Figure 3E,F), all in contrast to control mice. Histological sections revealed that the eustachian tube in mutant mice was heavily infiltrated by inflammatory cells (Figure 3G,H). Individual mutant mice showed differing degrees of middle ear inflammation, at various ages, with excessive effusion and inflammatory cells, most of which were neutrophilic granulocytes, along with a few macrophages (Figure 3I,J). Thus, the mucus-secreting ability of the middle ear epithelium was enhanced in the mutant mice, and the excretion ability of the eustachian tube was diminished, leading to excessive effusion in OM. To measure the degree of pathology in OM, five indices were used for semi-quantitative evaluation as shown in Table 1. These data revealed that all of the tested Sh3pxd2bnee mutant mice had signs of inflammation in their ears and that the degree of inflammation in ears of Sh3pxd2bnee mutant mice was significantly greater than that in ears of wild-type control mice.

Figure 2
H&E histology shows development of middle ear structures and pathology.
Figure 3
Signs of inflammation and otitis media in Sh3pxd2bnee mutant mice (M) compared with controls (WT).
Table 1
Semi-quantitative evaluation of the outcome of the middle ear inflammation in Sh3pxd2bnee mice.

Scanning electronic microscopy observation

We assessed changes in cilia and goblet cells of the middle ear mucosa from 21-day-old Sh3pxd2bnee mutant mice using scanning electronic microscopy. Wild-type littermate control mice displayed a thick lawn of morphologically normal, evenly distributed cilia in the mucociliary epithelia of the middle ears. In comparison, the cilia were diminished and sparsely distributed in the mucociliary epithelia of middle ears from Sh3pxd2bnee mutant mice. Furthermore, an elevated density of goblet cells was evident in the mutant middle ear mucosa. A high density of goblet cells was not found in the middle mucosa from the wild-type control mice. (Figure 4A–B).

Figure 4
Scanning electron microscopic view of the middle ear mucosa.

Craniofacial measurement

Craniofacial measurements showed that the mutant mice had a statistically significant (p<0.01) decreased linear distance between craniofacial landmarks for all but four measurements taken. The distances measured have been indicated by black lines in Figure 5. The average skull length (Figure 5A, landmark 1-landmark 20) of control mice was 22.00 mm; whereas, the average skull length of mutant mice was 16.08 mm. The average skull width (Figures 5A, landmark 19-landmark 21) of controls was 10.44 mm versus 8.91 mm for mutants. The average skull height (Figure 5E, landmark 14-landmark 44) for controls was 10.34 mm, versus 8.35 mm in mutants. The average lower jaw length (Figure 5E, landmark 40-landmark 38(39)) in controls was 11.71 mm, versus 8.63 mm in mutants. The average upper jaw length (Figure 5E, landmark 1-landmark 13(15)) in controls was 14.39 mm compared to 9.93 mm in mutants. The average nose length (Figure 5A, landmark 1-landmark 7) in controls was 10.28 mm, compared to 8.43 mm in mutants. The average interorbital distance (Figure 5A, landmark 6-landmark 8) in controls was 5.60 mm, compared to 5.29 mm in mutant mice. (Measurement data are not shown). All of these measurements showed statistically significant differences in the mean distances between mutant and control mice (p<0.01) except for the interorbital distances (p>0.05)(Figure 6A). Between the midline of the skull base and the bony part of the left and right eustachian tubes (angles 1 and 2 in Figure 6B,C), mutant mice had significantly larger angles in angle 1: 59.6° versus 40.3° for controls, and in angle 2: 59.64° versus 40.00° for controls (measurement data not shown) (Figure 6C, angle 1 and 2; P<0.01). Thus, there were clearly alterations that would produce a more horizontal orientation of the eustachian tubes in Sh3pxd2bnee mutant mice, paralleling the eustachian tube morphology in humans that may cause a predisposition for OM.

Figure 5
Landmarks and linear distances used in craniofacial measurement*.
Figure 6
Assessment of craniofacial dysmorphology in Sh3pxd2bnee mice.

Time-course ABR thresholds

ABR thresholds were measured in Sh3pxd2bnee mice and controls several times between one and six months of age and showed a consistent increase in mutant mice (Figure 7). ABR threshold mean values above 55 (for click stimuli), 40 (for 8 kHz), 35 (for 16 kHz) and 60 (for 32 kHz) decibel sound pressure levels (dB SPL) indicate hearing impairment [37]. There was a tendency toward elevation at higher stimulus frequencies both in mutant and control mice (Figure 7C,D; 16 kHz and 32 kHz). At each time point, the gap between ABR threshold mean values of mutant and control mice tended to decline as stimulus frequency was elevated (Figure 7B,C; 8 kHz and 16 kHz). Then we compared the normalized hearing level values from the mutant mice (each mutant hearing levels minus mean hearing level of wild-type), which represent the degree of hearing impairment, between the lower stimulus frequencies (8 kHz Figure 7B) and higher stimulus frequencies (32 kHz, Figure 7D). We found statistically significant differences at each time point (Student t test, P<0.005, 1 through 6 months). These results demonstrated that the mutation affects hearing at lower stimulus frequencies more than at higher stimulus frequencies.

Figure 7
Impaired hearing in Sh3pxd2bnee mice.

Increased mRNA and protein expression for Tnf-α and Tlr2

Gapdh-correlated, semi-quantitative RT-PCR analysis revealed that mRNA expression levels in the middle ear in four 24-day-old Sh3pxd2bnee mutant mice were increased for the pro-inflammatory cytokine Tnf-α and for cell surface receptor Tlr2 which aids in pathogen recognition (Figure 8, * P<0.05, **P<0.01, respectively).

Figure 8
Evidence of active inflammation in ear tissue of Sh3pxd2bnee mutants up-regulation of pro-inflammatory molecules.

To determine whether protein levels of TNF-α and TLR2 were upregulated in Sh3pxd2bnee mice, we analyzed the expression of each in situ. Paraffin sections of middle ears from control and Sh3pxd2bnee mutant 21-day-old mice were stained with anti-TNF-α and anti-TLR2. In the thickened epithelial walls of the middle ear cavity, TNF-α was upregulated in mutant mice compared to wild-type controls (Figure 9A–F). TLR2 immunostaining showed a very similar pattern to that seen for TNF-α (Figure 9G–L). In both cases, antibodies specific for TNF-α or TLR2 stained the middle ear mucosa of mutant mice much more brightly than the control samples and this staining was localized to the cytoplasm of epithelial cells and of inflammatory cells. The protein levels seen by immunohistochemistry correlated with the up-regulation of mRNA observed by RT-PCR.

Figure 9
Pro-inflammatory proteins detected in middle ears of Sh3pxd2bnee mutant mice.


In our study, we explored the hypothesis that gene mutation leading to craniofacial dysmorphology increases susceptibility to OM with effusion and we validated the Sh3pxd2bnee mutant mouse as an animal model for this. Craniofacial dysmorphology is heritable through gene mutation [37], but how mutations in genes linked to craniofacial development lead to pathologies such as OM is unclear [37], [38]. Using the Sh3pxd2bnee mouse model, we examined the role of Sh3pxd2b mutation in craniofacial dysmorphology and development of OM. Previous studies confirmed that mutation in Sh3pxd2b leads to craniofacial dysmorphology and OM [24]; our study examined OM progression and included hearing assessment throughout development. Together with measurement of middle ear inflammatory factor expression, our study more fully characterizes the OM and associated pathologies resulting from Sh3pxd2b mutation.

We compared craniofacial structural dimensions of control and mutant mice, analyzed middle and inner ear pathologies, and tested hearing thresholds through various developmental stages. We measured mRNA and protein expression of TNF-α and TLR2, previously reported in OM research [30], [34], [39], [40], [41], to determine whether these inflammatory factors were upregulated in mutant mice that developed inflammation of the middle ear. Our findings showed that all Sh3pxd2bnee mice were born with craniofacial dysmorphologies and developed OM, as early as 11 days of age, with associated pathologies progressively worsening. Furthermore, the mutant mice showed impaired hearing that was statistically more pronounced at lower frequencies. The type of hearing impairment caused by otitis media is conductive hearing loss when active otitis media exists. It is difficult to perform bone-conduction ABR in the mice because the mouse head is so small. In human patients with active otitis media, lower frequencies are more compromised than higher ones [42]. The mutant mice showed increased mRNA and protein levels of TNF-α and TLR2, which are consistent with the activation of inflammation pathways shared with other OM in mice and humans [29], [37], [43].

Agreeing with a previous study [24], our findings confirmed craniofacial dysmorphology in Sh3pxd2bnee mutant mice and, for the first time in this model, showed eustachian tube dysmorphology, which has been closely linked to OM development in children [1], [2]. Specifically, craniofacial dysmorphology led to a positional change of the eustachian tube. The angle between the midline of the skull base and the bony part of the eustachian tube was increased in mutant mice, on both the right and left sides, thus imparting a more horizontal orientation to the bony part of the eustachian tube. Other signs of pathology in the mutant mouse eustachian tube included thickened epithelium, presence of inflammatory cells, and a narrowed tympanic cavity opening of the eustachian tube. This is the first demonstration in mouse of these alterations of the eustachian tube which are associated with craniofacial dysmorphology and are all phenotypic outcomes that accompany OM.

Time-course examination of OM pathology progression revealed 11-day-old mutant mice with a much higher degree of middle ear effusion (a primary sign of OM) than control mice. By 2.5 months, mutant mice also showed fibroblast proliferation, and increased goblet cells and inflammatory cells. These phenotypic outcomes are consistent with findings in human patients [44], [45]. Older mice also exhibited more tissue repair reaction in the middle ears.

Cilia present on the mucociliary epithelia of the healthy middle ear are critical for the clearance of secretions. Goblet cells associated in normal numbers with the mucociliary epithelia of the middle ear mucosa are involved in the production of mucosal secretions and contribute to a normal immune response [38], [46], [47]. Our findings reveal morphological abnormalities of cilia in the mucociliary epithelia of middle ears that may cause an inability to clear secretions in Sh3pxd2bnee mutant mice. We also found a high density of goblet cells in the middle ear mucosa of mutant mice, which may further explain the accumulation of excessive exudate in the middle ear cavities of these mice.

Mutant mice demonstrated impaired hearing upon auditory brainstem response testing, which determines the minimum threshold of hearing at different sound frequencies. We examined hearing at ages 1, 2, 3, 5 and 6 months and found significantly impaired hearing as early as 1 month. A tendency toward increased hearing threshold with age was evident at higher frequencies. Overall, however, hearing impairment of mutant mice was more pronounced at lower frequencies. Thus, the pathological hearing effects associated with this mutation are complex because hearing is affected differently depending on sound frequency and mouse age.

When craniofacial dysmorphology is present, secretions cannot be cleared from the middle ear cavity through the eustachian tube, and bacteria can accumulate, leading to inflammation [38]. Failure to clear secretions because of eustachian tube dysfunction can probably explain the upregulation of inflammatory factors in Sh3pxd2bnee mice. Toll-like receptors (TLRs) function on host cell surfaces to recognize pathogens and recruit cytokines and other immune effectors. Other studies have shown that TLR2 was present in the middle ears of patients with OM [34], [39], [40], [41]. Our findings show that TLR2 was upregulated in the mutant mice.


Our study shows that a mutation in the Sh3pxd2b gene, which affects craniofacial development in mutant mice, led to OM that mimics the human disease in a number of important physiologic and metabolic parameters. This is the first mouse model to exhibit eustachian tube morphology that mimics the eustachian tube morphology in humans which has been linked to OM. Further examination of genes such as the Sh3pxd2b gene are warranted to further elucidate how these proteins are involved in onset and progression of craniofacial dysmorphology and OM. Identifying the relationships between Sh3pxd2b and other genes and between SH3PXD2B protein and other proteins is an important step toward understanding craniofacial development and the onset of OM, ultimately promoting treatment and prevention options.


We wish to thank Dr. Cindy Benedict-Alderfer for editing this manuscript and Linda Le for her help in the craniofacial measurement.


Competing Interests: The authors have declared that no competing interests exist.

Funding: This publication was supported by NIH grants R01DC007392 and R01DC009246. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.


1. Stool SE BA, Berman S, Carney CJ, Culpepper L, et al. Otitis Media with Effusion in Young Children. Clinical Practice Guideline; 1994.
2. Alho OP, Oja H, Koivu M, Sorri M. Chronic otitis media with effusion in infancy. How frequent is it? How does it develop? Arch Otolaryngol Head Neck Surg. 1995;121:432–436. [PubMed]
3. Rosenfeld RM, Culpepper L, Doyle KJ, Grundfast KM, Hoberman A, et al. Clinical practice guideline: Otitis media with effusion. Otolaryngol Head Neck Surg. 2004;130:S95–118. [PubMed]
4. Paradise JL, Rockette HE, Colborn DK, Bernard BS, Smith CG, et al. Otitis media in 2253 Pittsburgh-area infants: prevalence and risk factors during the first two years of life. Pediatrics. 1997;99:318–333. [PubMed]
5. Engel JA, Straetemans M, Zielhuis GA. Birth characteristics and recurrent otitis media with effusion in young children. Int J Pediatr Otorhinolaryngol. 2005;69:533–540. [PubMed]
6. Marchant CD, Shurin PA, Turczyk VA, Wasikowski DE, Tutihasi MA, et al. Course and outcome of otitis media in early infancy: a prospective study. J Pediatr. 1984;104:826–831. [PubMed]
7. Klein JO. The burden of otitis media. Vaccine. 2000;19(Suppl 1):S2–8. [PubMed]
8. Cunsolo E, Marchioni D, Leo G, Incorvaia C, Presutti L. Functional anatomy of the Eustachian tube. Int J Immunopathol Pharmacol. 2010;23:4–7. [PubMed]
9. Pau HW, Sievert U, Just T, Sade J. Pressure changes in the human middle ear without opening the eustachian tube. Acta Otolaryngol. 2009;129:1182–1186. [PubMed]
10. Makibara RR, Fukunaga JY, Gil D. Eustachian tube function in adults with intact tympanic membrane. Braz J Otorhinolaryngol. 2010;76:340–346. [PubMed]
11. Doyle WJ, Swarts JD. Eustachian tube-Tensor veli palatini muscle-cranial base relationships in children and adults: an osteological study. Int J Pediatr Otorhinolaryngol. 2010;74:986–990. [PMC free article] [PubMed]
12. Sehhati-Chafai-Leuwer S, Wenzel S, Bschorer R, Seedorf H, Kucinski T, et al. Pathophysiology of the Eustachian tube–relevant new aspects for the head and neck surgeon. J Craniomaxillofac Surg. 2006;34:351–354. [PubMed]
13. Granstrom G. Middle ear infections. Periodontol 2000. 2009;49:179–193. [PubMed]
14. Kemaloglu YK, Kobayashi T, Nakajima T. Associations between the eustachian tube and craniofacial skeleton. Int J Pediatr Otorhinolaryngol. 2000;53:195–205. [PubMed]
15. Visosky AM, Johnson J, Bingea B, Gurney T, Lalwani AK. Otolaryngological manifestations of cleidocranial dysplasia, concentrating on audiological findings. Laryngoscope. 2003;113:1508–1514. [PubMed]
16. Richardson MA, Donaldson JA. Middle ear fluid. Am Fam Physician. 1981;23:159–163. [PubMed]
17. Di Francesco R, Paulucci B, Nery C, Bento RF. Craniofacial morphology and otitis media with effusion in children. Int J Pediatr Otorhinolaryngol. 2008;72:1151–1158. [PubMed]
18. Di Francesco RC, Sampaio PL, Bento RF. Correlation between otitis media and craniofacial morphology in adults. Ear Nose Throat J. 2007;86:738–743. [PubMed]
19. Todd NW. Cranial anatomy and otitis media: a cadaver study. Am J Otol. 1998;19:558–564. [PubMed]
20. Flynn T, Moller C, Jonsson R, Lohmander A. The high prevalence of otitis media with effusion in children with cleft lip and palate as compared to children without clefts. Int J Pediatr Otorhinolaryngol 2009 [PubMed]
21. Sheahan P, Miller I, Sheahan JN, Earley MJ, Blayney AW. Incidence and outcome of middle ear disease in cleft lip and/or cleft palate. Int J Pediatr Otorhinolaryngol. 2003;67:785–793. [PubMed]
22. Purzycki A, Thompson E, Argenta L, David L. Incidence of otitis media in children with deformational plagiocephaly. J Craniofac Surg. 2009;20:1407–1411. [PubMed]
23. Buschman MD, Bromann PA, Cejudo-Martin P, Wen F, Pass I, et al. The novel adaptor protein Tks4 (SH3PXD2B) is required for functional podosome formation. Mol Biol Cell. 2009;20:1302–1311. [PMC free article] [PubMed]
24. Mao M, Thedens DR, Chang B, Harris BS, Zheng QY, et al. The podosomal-adaptor protein SH3PXD2B is essential for normal postnatal development. Mamm Genome. 2009;20:462–475. [PMC free article] [PubMed]
25. Diaz B, Shani G, Pass I, Anderson D, Quintavalle M, et al. Tks5-dependent, nox-mediated generation of reactive oxygen species is necessary for invadopodia formation. Sci Signal. 2009;2:ra53. [PMC free article] [PubMed]
26. Gianni D, Diaz B, Taulet N, Fowler B, Courtneidge SA, et al. Novel p47(phox)-related organizers regulate localized NADPH oxidase 1 (Nox1) activity. Sci Signal. 2009;2:ra54. [PMC free article] [PubMed]
27. Weaver AM. Regulation of cancer invasion by reactive oxygen species and Tks family scaffold proteins. Sci Signal. 2009;2:pe56. [PMC free article] [PubMed]
28. Iqbal Z, Cejudo-Martin P, de Brouwer A, van der Zwaag B, Ruiz-Lozano P, et al. Disruption of the podosome adaptor protein TKS4 (SH3PXD2B) causes the skeletal dysplasia, eye, and cardiac abnormalities of Frank-Ter Haar Syndrome. Am J Hum Genet. 2010;86:254–261. [PMC free article] [PubMed]
29. Han F, Yu H, Zhang J, Tian C, Schmidt C, et al. Otitis media in a mouse model for Down syndrome. Int J Exp Pathol. 2009;90:480–488. [PMC free article] [PubMed]
30. Han F, Yu H, Tian C, Li S, Jacobs MR, et al. Role for Toll-like receptor 2 in the immune response to Streptococcus pneumoniae infection in mouse otitis media. Infect Immun. 2009;77:3100–3108. [PMC free article] [PubMed]
31. Green MC. A rapid method for clearing and staining specimens for the demonstration of bone. . The Ohio Journal of Science. 1952;52(1):31–33.
32. Richtsmeier JT, Baxter LL, Reeves RH. Parallels of craniofacial maldevelopment in Down syndrome and Ts65Dn mice. Dev Dyn. 2000;217:137–145. [PubMed]
33. Zheng QY, Johnson KR, Erway LC. Assessment of hearing in 80 inbred strains of mice by ABR threshold analyses. Hear Res. 1999;130:94–107. [PMC free article] [PubMed]
34. Lee YC, Kim C, Shim JS, Byun JY, Park MS, et al. Toll-like receptors 2 and 4 and their mutations in patients with otitis media and middle ear effusion. Clin Exp Otorhinolaryngol. 2008;1:189–195. [PMC free article] [PubMed]
35. Ungkanont K, Charuluxananan S, Komoltri C. Association of otoscopic findings and hearing level in pediatric patients with otitis media with effusion. Int J Pediatr Otorhinolaryngol. 2010;74:1063–1066. [PubMed]
36. Kemaloglu YK, Beder L, Sener T, Goksu N. Tympanometry and acoustic reflectometry in ears with chronic retraction without effusion. Int J Pediatr Otorhinolaryngol. 2000;55:21–27. [PubMed]
37. Trune DR, Zheng QY. Mouse models for human otitis media. Brain Res. 2009;1277:90–103. [PMC free article] [PubMed]
38. Depreux FF, Darrow K, Conner DA, Eavey RD, Liberman MC, et al. Eya4-deficient mice are a model for heritable otitis media. J Clin Invest. 2008;118:651–658. [PMC free article] [PubMed]
39. Harimaya A, Fujii N, Himi T. Preliminary study of proinflammatory cytokines and chemokines in the middle ear of acute otitis media due to Alloiococcus otitidis. Int J Pediatr Otorhinolaryngol. 2009;73:677–680. [PubMed]
40. Leichtle A, Hernandez M, Pak K, Yamasaki K, Cheng CF, et al. TLR4-mediated induction of TLR2 signaling is critical in the pathogenesis and resolution of otitis media. Innate Immun. 2009;15:205–215. [PMC free article] [PubMed]
41. Samuel EA, Burrows A, Kerschner JE. Cytokine regulation of mucin secretion in a human middle ear epithelial model. Cytokine. 2008;41:38–43. [PMC free article] [PubMed]
42. Silveira Netto LF, da Costa SS, Sleifer P, Braga ME. The impact of chronic suppurative otitis media on children's and teenagers' hearing. Int J Pediatr Otorhinolaryngol. 2009;73:1751–1756. [PubMed]
43. Zheng QY, Hardisty-Hughes R, Brown SD. Mouse models as a tool to unravel the genetic basis for human otitis media. Brain Res. 2006;1091:9–15. [PMC free article] [PubMed]
44. Juhn SK, Jung TT. Inflammatory changes reflected in middle ear effusion in otitis media. Auris Nasus Larynx. 1985;12(Suppl 1):S63–66. [PubMed]
45. Lin J, Tsuboi Y, Rimell F, Liu G, Toyama K, et al. Expression of mucins in mucoid otitis media. J Assoc Res Otolaryngol. 2003;4:384–393. [PMC free article] [PubMed]
46. Saunders J, Murray M, Alleman A. Biofilms in chronic suppurative otitis media and cholesteatoma: scanning electron microscopy findings. Am J Otolaryngol. 2011;32:32–37. [PubMed]
47. Jang CH, Park H, Choi CH, Cho YB, Park IY. Efficacy of transnasal nebulized surfactant on experimental otitis media with effusion in guinea pig. Int J Pediatr Otorhinolaryngol. 2010;74:71–74. [PubMed]

Articles from PLoS ONE are provided here courtesy of Public Library of Science
PubReader format: click here to try


Save items

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...